Brian MacDonald's most recent trade in Norwegian Cruise Line Holdings Ltd was a trade of 15,000 Common Stock done at an average price of $16.5 . Disclosure was reported to the exchange on May 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Norwegian Cruise Line | Brian Patrick MacDonald | Director | Purchase of securities on an exchange or from another person at price $ 16.54 per share. | 11 May 2026 | 15,000 | 23,912 (0%) | 0% | 16.5 | 248,100 | Common Stock |
| Norwegian Cruise Line | Brian Patrick MacDonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2026 | 8,912 | 8,912 (0%) | 0% | 0 | Common Stock | |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 44.85 per share. | 28 Jun 2023 | 2,923 | 14,277 | - | 44.9 | 131,102 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 49.24 per share. | 28 Jun 2023 | 2,247 | 25,153 | - | 49.2 | 110,649 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 45.49 per share. | 28 Jun 2023 | 2,230 | 19,334 | - | 45.5 | 101,453 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 46.51 per share. | 28 Jun 2023 | 1,934 | 17,400 | - | 46.5 | 89,952 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 50.38 per share. | 28 Jun 2023 | 1,900 | 23,253 | - | 50.4 | 95,730 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 45.45 per share. | 28 Jun 2023 | 1,401 | 12,876 | - | 45.5 | 63,676 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 50.80 per share. | 28 Jun 2023 | 953 | 22,300 | - | 50.8 | 48,415 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 44.37 per share. | 28 Jun 2023 | 736 | 21,564 | - | 44.4 | 32,656 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 46.76 per share. | 28 Jun 2023 | 600 | 12,276 | - | 46.8 | 28,058 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 47.24 per share. | 28 Jun 2023 | 200 | 17,200 | - | 47.2 | 9,448 | Common Stock |
| Disc Medicine Inc | Brian MacDonald | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2022 | 33,847 | 33,847 | - | - | Stock Option (Right to Buy) |